Onychomycosis accounts for one third of fungal skin infections. Because only about one half of nail dystrophies are caused by fungus, the diagnosis should be confirmed by potassium hydroxide preparation, culture or histology before treatment is started. Newer, more effective antifungal agents have made treating onychomycosis easier. Terbinafine and itraconazole are the therapeutic agents of choice. Although the U.S. Food and Drug Administration has not labeled fluconazole for the treatment of onychomycosis, early efficacy data are promising. Continuous oral terbinafine therapy is most effective against dermatophytes, which are responsible for the majority of onychomycosis cases. Intermittent pulse dosing with itraconazole is as safe and effective as short-term continuous therapy but more economical and convenient. With careful monitoring, patients treated with the newer antifungal agents have a good chance of achieving relief from onychomycosis and its complications.
Photodynamic therapy for Onychomycosis
Onychomycosis Treatment Market Size, Growth Trends, Forecast 2030
Toenail Fungus Treatment Treatment using a PACT Machine
Over The Counter Treatments For Onychomycosis — FOOT & ANKLE CENTERS
Novel Discoveries and Clinical Advancements for Treating
Miami Center for Cosmetic Dermatology – Dr. Deborah LongwillCoolsculpting Miami
Pediatric Onychomycosis: The Emerging Role of Topical Therapy
Toenail Fungus Treatment Nail Fungus Laser Treatment Device for
Systemic Therapy of Onychomycosis
Nail Fungus Removal Serum Foot Nails Care Products Anti Fungus
A Complete Guide to Toenail Fungus Treatment
Laser Toenail Therapy